AB&B BIO-TECH-B (02627) has announced that Ms. Li Runxiang has resigned from her roles as executive director and chief financial officer of the company, effective September 23, 2026.

Dr. Chen Ze and Ms. Wu Jingyun have both been nominated as candidates for executive director on the second board of directors, subject to shareholder approval at the company's general meeting. Ms. Wu has also been appointed as chief financial officer, effective September 23, 2026.

Effective from September 23, 2026, Ms. Li has stepped down from her positions as a member of the Remuneration and Assessment Committee and the Board Nomination Committee. Mr. He Yiming has been appointed as a member of the Remuneration and Assessment Committee, while Ms. Lei Meijia has been appointed as a member of the Nomination Committee.

Mr. Xu Jian has been appointed as company secretary and joint company secretary, effective September 23, 2026. Following Ms. Li's resignation as executive director, she has ceased to be the authorized representative appointed under Rule 3.05 of the Listing Rules, and Mr. Xu has been appointed to replace her in that capacity, also effective September 23, 2026.